NCT02239029View on ClinicalTrials.gov

Platelet Rich Plasma on Osteoarthritis of Knee

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Knee Osteoarthritis
Interventions
DRUG

platelet rich plasma

Platelet rich plasma (PRP) is a new and potential treatment for patients with kinds of musculoskeletal disorders.

DRUG

Normal saline

The normal salin as the placebo intervention was injection in the other side of knee.

Trial Locations (1)

886

Tri-Service General Hospital, National Defense Medical Center,, Taipei

All Listed Sponsors
lead

Yung-Tsan Wu

OTHER

NCT02239029 - Platelet Rich Plasma on Osteoarthritis of Knee | Biotech Hunter | Biotech Hunter